Ziltivekimab

Intervention1 paper2 findings

Outcomes

1

Major adverse cardiovascular events

no changein humans1

1 study

  1. Ziltivekimab has no effect on major adverse cardiovascular events in humans.

    Reviewin CKD

    Targeting Inflammation in Chronic Kidney Disease: Pathophysiological Insights and Emerging Therapeutic Strategies · Journal of clinical medicine · 25 Aug 2026

Associations

1

Serious infections

upin humans1

1 study

  1. Ziltivekimab raises the risk of serious infections in humans.

    Reviewin CKD

    Targeting Inflammation in Chronic Kidney Disease: Pathophysiological Insights and Emerging Therapeutic Strategies · Journal of clinical medicine · 25 Aug 2026

Serious infections →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01

Related